Sylvie Alonso Selected Research

balapiravir

1/2018

Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvie Alonso Research Topics

Disease

33	Infections 01/2021 - 08/2002
19	Dengue (Dengue Fever) 12/2021 - 02/2008
10	Tuberculosis (Tuberculoses) 11/2021 - 09/2004
9	Whooping Cough (Pertussis) 07/2014 - 08/2002
6	Communicable Diseases (Infectious Diseases) 01/2019 - 09/2004
5	Severe Dengue 12/2021 - 01/2016
3	Viremia 11/2021 - 04/2010
3	Hypoxia (Hypoxemia) 01/2021 - 01/2013
2	Neoplasms (Cancer) 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 07/2010
2	Granuloma 11/2016 - 10/2010
1	Human Influenza (Influenza) 01/2022
1	COVID-19 01/2022
1	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2020
1	Convalescence 10/2017
1	Fever (Fevers) 10/2017
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2017
1	Mycobacterium Infections (Infections, Mycobacterium) 09/2013
1	Pathologic Processes 09/2013
1	Shock 01/2013

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 01/2022 - 08/2002
9	AntibodiesIBA 12/2021 - 08/2002
9	Pharmaceutical PreparationsIBA 11/2021 - 08/2008
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2004
5	CytokinesIBA 01/2019 - 07/2010
4	Neutralizing AntibodiesIBA 01/2018 - 09/2007
3	Polysaccharides (Glycans)IBA 04/2019 - 03/2010
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 04/2011
3	Antiviral Agents (Antivirals)IBA 11/2016 - 10/2014
2	bedaquiline (R207910)IBA 11/2021 - 08/2008
2	Oxidoreductases (Dehydrogenase)IBA 11/2021 - 11/2017
2	Heparitin Sulfate (Heparan Sulfate)IBA 06/2021 - 10/2017
2	Hyaluronic Acid (Hyaluronan)IBA 06/2021 - 10/2017
2	Complement System Proteins (Complement)IBA 01/2021 - 03/2010
2	Interferon Receptors (Interferon Receptor)IBA 01/2019 - 02/2012
2	Monoclonal AntibodiesIBA 01/2018 - 01/2012
2	AntigensIBA 10/2017 - 01/2008
2	Ethionamide (Trecator-SC)FDA Link 01/2017 - 05/2014
2	Capsules (Microcapsules)IBA 01/2014 - 03/2010
2	4-1BB Ligand (4 1BB Ligand)IBA 01/2014 - 06/2013
2	Interleukin-12 (IL 12)IBA 01/2014 - 06/2012
2	CarbonIBA 01/2013 - 08/2012
2	EpitopesIBA 01/2012 - 08/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2021
1	Drug CombinationsIBA 11/2021
1	Metformin (Glucophage)FDA LinkGeneric 11/2021
1	CytochromesIBA 11/2021
1	Attenuated VaccinesIBA 01/2021
1	PeripherinsIBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	Complement Factor B (Factor B)IBA 01/2021
1	Dengue VaccinesIBA 01/2021
1	Complement Factor H (Factor H)IBA 01/2021
1	AcetylglucosamineIBA 04/2019
1	Viral Envelope ProteinsIBA 04/2019
1	Mannose (D-Mannose)IBA 04/2019
1	Bacterial VaccinesIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2019
1	ProhibitinsIBA 01/2018
1	rocaglamideIBA 01/2018
1	celgosivirIBA 01/2018
1	balapiravirIBA 01/2018
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2018
1	Chloroquine (Aralen)FDA LinkGeneric 01/2018
1	Serum AlbuminIBA 10/2017
1	Interleukin-10 (Interleukin 10)IBA 10/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	dual specificity phosphatase 12IBA 01/2017
1	ChemokinesIBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	p38 Mitogen-Activated Protein KinasesIBA 01/2017
1	Dual Specificity Phosphatase 1IBA 01/2017
1	RibonucleosidesIBA 11/2016
1	acceleratory factor from growth hormone (AcG)IBA 11/2016
1	Codon (Codons)IBA 11/2016
1	Thr Transfer RNAIBA 11/2016
1	Transfer RNA (tRNA)IBA 11/2016
1	CathelicidinsIBA 09/2016
1	InterferonsIBA 03/2016
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Immunodominant EpitopesIBA 07/2015
1	NucleosidesIBA 10/2014
1	Viral ProteinsIBA 10/2014
1	Antitubercular AgentsIBA 05/2014
1	Carrier Proteins (Binding Protein)IBA 01/2014
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2014
1	PolymersIBA 01/2014
1	Interleukin-17 (Interleukin 17)IBA 01/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2014
1	Macrophage Colony-Stimulating FactorIBA 09/2013
1	telacebecIBA 09/2013

Therapy/Procedure

4	Therapeutics 11/2015 - 08/2008
3	Intranasal Administration 07/2010 - 08/2002
2	Immunotherapy 01/2019 - 01/2018
2	Resuscitation 11/2016 - 01/2013
1	Oral Administration 11/2021